MarketPeel
Insider Trading Intelligence
Pricing
…
RD

Raymond Debbane

WW
DIRECTOR · WW INTERNATIONAL, INC. · CIK 0001053890
FILING MIX · LIFETIME80%/20%
BUYS
55
SELLS
14
TOTAL VALUE
$156.46M
COMPANIES
3
ACTIVE SINCE
Dec 2019
HOLDINGS NOW
10,959,400
AVG SELL PX
$41.01
TRADE KIND
SHOWING 69 / 69
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
19 backtested trades · 8 horizons · 30 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Raymond Debbane, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d19+57.89%+5.34%+0.46%+4.89%+2.73%—
14d19+68.42%+15.51%-0.36%+15.87%+17.09%—
30d19+52.63%+11.65%-2.01%+13.66%+19.82%—
60d19+68.42%+16.91%+1.30%+15.61%+13.90%—
90d19+89.47%+24.31%+2.86%+17.20%+11.49%—
180d19(8 pending)+81.82%+11.73%+4.38%+7.35%-18.00%—
1y19(8 pending)+27.27%+15.42%+19.08%-3.66%-3.75%—
2y19(14 pending)+60.00%+15.48%+46.19%-30.70%-13.40%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
WW · 134,387 shares · as of May 9, 2023
033,59767,194100,790134,3872020202120222023SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2019
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 55 buys / 14 sellsCOVERAGE · 27 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
LXRX
LEXICON PHARMACEUTICALS, INC.
SALE
89,312——0Jun 3, 2026Jun 4, 2026 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
89,312——1,995,498Jun 3, 2026Jun 4, 2026 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
43,478——43,478May 1, 2026May 4, 2026 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
35,714——35,714May 1, 2026May 4, 2026 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
2,000$1.49$3.0K1,906,186Feb 25, 2026Feb 27, 2026 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
100,000$1.47$147.0K1,904,186Feb 23, 2026Feb 25, 2026 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
100,000$1.48$147.8K1,804,186Feb 20, 2026Feb 23, 2026 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
50,000$1.44$72.0K1,704,186Feb 19, 2026Feb 23, 2026 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
133,688$1.32$176.5K1,654,186Feb 18, 2026Feb 18, 2026 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
76,857$1.31$100.5K1,520,498Feb 17, 2026Feb 18, 2026 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
57,952$1.31$75.9K1,443,641Feb 13, 2026Feb 18, 2026 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
1,538,462$1.30$2.00M1,538,462Feb 2, 2026Feb 4, 2026 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
18,553,846$1.30$24.12M154,734,327Feb 2, 2026Feb 4, 2026 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
367,145.12$65.00$23.86M367,145.12Feb 2, 2026Feb 4, 2026 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
3,846,154$1.30$5.00M7,362,368Feb 2, 2026Feb 4, 2026 ↗View →
SRRK
SCHOLAR ROCK HOLDING CORP
SALE
1,575,008——0Dec 11, 2025Feb 6, 2026 ↗View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASE
1,575,008$7.35$11.58M10,825,013Dec 11, 2025Feb 6, 2026 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
89,312——89,312Jun 3, 2025Jun 3, 2025 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
103,806——103,806Jun 3, 2025Jun 3, 2025 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
36,810——1,385,689May 13, 2025May 13, 2025 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
SALE
36,810——0May 13, 2025May 13, 2025 ↗View →
SRRK
SCHOLAR ROCK HOLDING CORP
SALE
1,600,000$41.65$66.64M9,250,005Dec 10, 2024Dec 12, 2024 ↗View →
SRRK
SCHOLAR ROCK HOLDING CORP
SALE
43,887$38.43$1.69M11,007,279Nov 25, 2024Nov 27, 2024 ↗View →
SRRK
SCHOLAR ROCK HOLDING CORP
SALE
126,442$39.51$5.00M10,880,837Nov 25, 2024Nov 27, 2024 ↗View →
SRRK
SCHOLAR ROCK HOLDING CORP
SALE
208,272$37.63$7.84M11,051,166Nov 25, 2024Nov 27, 2024 ↗View →
SRRK
SCHOLAR ROCK HOLDING CORP
SALE
149$40.98$6.1K10,850,005Nov 25, 2024Nov 27, 2024 ↗View →
SRRK
SCHOLAR ROCK HOLDING CORP
SALE
30,683$40.14$1.23M10,850,154Nov 25, 2024Nov 27, 2024 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
44,906——44,906May 13, 2024May 13, 2024 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
36,810——36,810May 13, 2024May 13, 2024 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
SALE
8,032——0Apr 28, 2024Apr 29, 2024 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
8,032——1,348,879Apr 28, 2024Apr 29, 2024 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
148,820$1.03$153.8K1,340,847Oct 12, 2023Oct 12, 2023 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
342,874$1.08$370.8K1,192,027Oct 11, 2023Oct 12, 2023 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
508,306$1.14$579.4K849,153Oct 10, 2023Oct 12, 2023 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
SALE
9,302——0May 21, 2023May 22, 2023 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
9,302——340,847May 21, 2023May 22, 2023 ↗View →
WW
WW INTERNATIONAL, INC.
PURCHASEGRANT
Stock grant
835——134,387May 9, 2023May 11, 2023 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
12,658——12,658Apr 28, 2023Apr 28, 2023 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
8,032——8,032Apr 28, 2023Apr 28, 2023 ↗View →
WW
WW INTERNATIONAL, INC.
PURCHASEGRANT
Stock grant
2,053——133,552Apr 3, 2023Apr 5, 2023 ↗View →
WW
WW INTERNATIONAL, INC.
PURCHASEGRANT
Stock grant
5,067——131,499Jan 2, 2023Jan 4, 2023 ↗View →
WW
WW INTERNATIONAL, INC.
PURCHASE
75,000$4.27$320.1K126,432Nov 10, 2022Nov 15, 2022 ↗View →
WW
WW INTERNATIONAL, INC.
PURCHASEGRANT
Stock grant
4,595——51,432Oct 3, 2022Oct 5, 2022 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
147,390$2.50$368.5K5,451,204Aug 5, 2022Aug 9, 2022 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
982,600$2.50$2.46M5,303,814Aug 1, 2022Aug 1, 2022 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
982,600$2.50$2.46M5,303,814Aug 1, 2022Aug 1, 2022 ↗View →
WW
WW INTERNATIONAL, INC.
PURCHASEGRANT
Stock grant
2,745——46,837Jul 4, 2022Jul 6, 2022 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
14,402——14,402May 21, 2022May 23, 2022 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
9,302——9,302May 21, 2022May 23, 2022 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
4,024——331,545Apr 30, 2022May 2, 2022 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
SALE
4,024——0Apr 30, 2022May 2, 2022 ↗View →
WW
WW INTERNATIONAL, INC.
PURCHASEGRANT
Stock grant
1,797——44,092Apr 4, 2022Apr 6, 2022 ↗View →
WW
WW INTERNATIONAL, INC.
PURCHASEGRANT
Stock grant
1,179$15.90$18.7K42,295Jan 3, 2022Jan 5, 2022 ↗View →
WW
WW INTERNATIONAL, INC.
PURCHASEGRANT
Stock grant
998$18.78$18.7K41,116Oct 4, 2021Oct 6, 2021 ↗View →
WW
WW INTERNATIONAL, INC.
PURCHASEGRANT
Stock grant
523$35.84$18.7K40,118Jul 5, 2021Jul 7, 2021 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
4,024——4,024Apr 30, 2021May 3, 2021 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
6,475——6,475Apr 30, 2021May 3, 2021 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
10,638——327,521Apr 24, 2021Apr 27, 2021 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
SALE
10,638——0Apr 24, 2021Apr 27, 2021 ↗View →
WW
WW INTERNATIONAL, INC.
PURCHASEGRANT
Stock grant
609$30.77$18.7K39,595Apr 5, 2021Apr 7, 2021 ↗View →
WW
WW INTERNATIONAL, INC.
PURCHASEGRANT
Stock grant
724——38,986Jan 4, 2021Jan 6, 2021 ↗View →
WW
WW INTERNATIONAL, INC.
PURCHASEGRANT
Stock grant
996——38,262Sep 28, 2020Sep 30, 2020 ↗View →
WW
WW INTERNATIONAL, INC.
PURCHASEGRANT
Stock grant
740——37,266Jun 29, 2020Jul 1, 2020 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
SALE
3,466——0Apr 26, 2020Apr 27, 2020 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
3,466——316,883Apr 26, 2020Apr 27, 2020 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
10,638——10,638Apr 24, 2020Apr 27, 2020 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
18,115——18,115Apr 24, 2020Apr 27, 2020 ↗View →
WW
WW INTERNATIONAL, INC.
PURCHASEGRANT
Stock grant
1,128——36,526Mar 30, 2020Apr 1, 2020 ↗View →
WW
WW INTERNATIONAL, INC.
PURCHASEGRANT
Stock grant
469——35,398Dec 30, 2019Jan 2, 2020 ↗View →
Other insiders · WW
Loading peer insiders…
About this filer
CIK 0001053890
ROLE
Director
PRIMARY
WW
COMPANIES
3
ACTIVE SINCE
Dec 2019
MARKETPEEL · /INSIDER/0001053890DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback